pMinDis.X513-iNicSnFR3b-(V7)-PM
(Plasmid
#125124)
-
PurposeDevelop a family of genetically encoded fluorescent biosensors for nicotine, termed iNicSnFRs thus enabling optical subcellular pharmacokinetics for nicotine
-
Depositing Lab
-
Depositing OrganizationCalifornia Institute of Technology
Located in the United States of America -
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 125124 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
| DNA | 125124-D50 | 50 μg of DNA in Tris buffer | $495 | ||
| DNA | 125124-D100 | 100 μg of DNA in Tris buffer | $585 | ||
Backbone
-
Vector backbonepMinDis.X513
-
Backbone manufacturerJanelia
- Backbone size w/o insert (bp) 5005
- Total vector size (bp) 6832
-
Vector typeMammalian Expression
-
Selectable markersNA
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Growth instructionsUse BL21(DE3) for bacterial expression and grow at 30 degrees C
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameiNicSnFR3b-(V7)-PM
-
Alt nameiNicSnFR3b-(V7)-PM
-
SpeciesMammalian
-
Insert Size (bp)1827
- Promoter T7
-
Tags
/ Fusion Proteins
- membrane anchoring protein-PDGFR (C terminal on insert)
- Ig-K-Chain (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BglII (unknown if destroyed)
- 3′ cloning site pstI (unknown if destroyed)
- 5′ sequencing primer T7
- 3′ sequencing primer BGH reverse
- (Common Sequencing Primers)
Resource Information
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please note that a 6bp insertion was identified in the NeoR/KanR cassette during Addgene's quality control process. We recommend testing NeoR selection before performing experiments. Vector was received from Janelia HHMI.
DNA (Catalog # 125124-D50)
Purpose
Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.
Delivery
- Amount 50 μg
- Concentration 1 μg/μL
- Pricing $495 USD
- Storage 4 ℃ (short-term) or -20 ℃ (long-term)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Quality Control
Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.
Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.
DNA (Catalog # 125124-D100)
Purpose
Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.
Delivery
- Amount 100 μg
- Concentration 1 μg/μL
- Pricing $585 USD
- Storage 4 ℃ (short-term) or -20 ℃ (long-term)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Quality Control
Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.
Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pMinDis.X513-iNicSnFR3b-(V7)-PM was a gift from Henry Lester (Addgene plasmid # 125124 ; http://n2t.net/addgene:125124 ; RRID:Addgene_125124) -
For your References section:
Determining the pharmacokinetics of nicotinic drugs in the endoplasmic reticulum using biosensors. Shivange AV, Borden PM, Muthusamy AK, Nichols AL, Bera K, Bao H, Bishara I, Jeon J, Mulcahy MJ, Cohen B, O'Riordan SL, Kim C, Dougherty DA, Chapman ER, Marvin JS, Looger LL, Lester HA. J Gen Physiol. 2019 Feb 4. pii: jgp.201812201. doi: 10.1085/jgp.201812201. 10.1085/jgp.201812201 PubMed 30718376